Form 4 for ELV Elevance Health
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001156039-24-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-05 | 2024-03-01 | ELV | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +2,755 | 23.0K | +14% | $0 |
| D | 2024-03-05 | 2024-03-01 | ELV | Kaye Mark | EVP, CFO | A - Grant | $0.00 | +10.6K | 10.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 2,755 | $0.00 | 23,031 | D | — | — | (F1) Represents restricted share units. Restrictions lapse as follows: 918 shares each on 3/1/2025 and 3/1/2026 and 919 shares on 3/1/2027. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-03-01 | A | A | 10,633 | $0.00 | 10,633 | D | $499.11 · — to 2034-03-01 | 10,633 Common Stock | (F2) The option represents a right to purchase a total of 10,633 shares, and is exercisable in two installments of 3,544 shares each, and one installment of 3,545 shares, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. |